NL-OMON39629招募中不适用
Infliximab top-down in pediatric Crohn's disease - Infliximab top-down in pediatric Crohn's disease/ITSKids
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •Children (age 3-17 yrs) with new-onset CD with moderate-to-severe disease activity assessed by a PCDAI (pediatric Crohn's disease activity score) >= 30 after a diagnosis of Crohn's disease.
排除标准
- •Patients with disease limited to the ileocoecal region, immediate need for surgery, symptomatic stenosis or stricture in the bowel due to scarring, severe co-morbidity, infection, a positive tuberculin test or a chest radiograph consistent with tuberculosis or a malignancy. Patients that have already started drug treatment.
研究者
相似试验
进行中（未招募）
不适用
Infliximab as firsdt treatment instead of second line treatment in Crohns diseaseCrohn's diseaseEUCTR2012-000645-13-BEErasmusMC90
进行中（未招募）
不适用
Infliximab as first treatment instead of second line treatment in Crohns diseaseCrohn's diseaseEUCTR2012-000645-13-NLErasmusMC90
招募中
4 期
Top-Down Infliximab Study in Kids with Crohn's disease (TISKids)Inflammatory bowel disease10017969Crohn's diseaseNL-OMON52984Erasmus MC, Universitair Medisch Centrum Rotterdam30
进行中（未招募）
1 期
Early infliximab use in kids with Crohn's disease (TISKids)Crohn's diseaseEUCTR2014-005702-37-NLErasmus Medical Center100
已完成
4 期
Top-down Infliximab Study in Kids With Crohn's DiseaseCrohn's DiseaseNCT02517684Erasmus Medical Center100